معرفی
David Gurevich is a Dr Sir Henry Dale University Research Fellow and Proleptic Lecturer in the Department of Life Sciences at the University of Bath, Faculty of Science. He is affiliated with the Centre for Therapeutic Innovation and the Centre for Bioengineering & Biomedical Technologies (CBio), reflecting his interdisciplinary research in developmental and regenerative biology. He is actively involved in research, supervising doctoral students, and collaborating with institutions such as Monash University and the Victor Chang Cardiac Research Institute.
Research Interests: His work focuses on understanding the cellular and molecular mechanisms underlying tissue regeneration and development, primarily using zebrafish models. Key areas include stem cell biology, organogenesis, signaling pathways (Wnt, Notch, Hippo), and immune-regeneration interactions. His research integrates live imaging, single-cell genomics, and genetic screening to uncover fundamental principles of regenerative processes.
The trends in his recent publications show a consistent focus on regenerative mechanisms across multiple organs—heart, retina, fin, kidney—highlighting a systems-level approach to understanding repair and development. His work bridges developmental biology, bioengineering, and translational medicine, contributing to the broader field of regenerative therapies.
Scientific Awards:
- Sir Henry Dale Fellowship
Advising and Grants: Dr Gurevich is accepting doctoral students and leads independent research supported by the Sir Henry Dale Fellowship, a prestigious award jointly funded by the Royal Society and Wellcome Trust. His collaborative network spans multiple departments at the University of Bath and international institutions, indicating active grant involvement and mentoring responsibilities.
Labs and Teams: He is embedded in interdisciplinary research centers including CBio and the Centre for Therapeutic Innovation, working alongside experts in bioengineering, mathematical modeling, and clinical translation. His lab likely operates within a collaborative, team-science framework focused on advancing regenerative medicine through innovative experimental approaches.
